Searched for
BSE SHARES PIRAMAL PHARMA
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...- Oil slide powers India's stock benchmarks to longest weekly winning run 7 monthsIndian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...
- Alpha Wave sells entire 1.9% stake in Delhivery; stock falls over 2%Global investment firm Alpha Wave Global has divested its entire 1.93% stake in logistics giant Delhivery for Rs 665 crore. This significan...
- Sterlite Technologies surges 5% on QIP launch, sets Rs 613.69 floor priceSterlite Technologies' stock climbed nearly 5% to Rs 613.35 as it officially launched its Qualified Institutions Placement (QIP) to bolster...
- Stocks to buy in 2026 for long term: Tata Capital, Tata Motors among 5 stocks that could give 10-20% returnWe have collated a list of recommendations from top brokerage firms from ETNow and other sources
- 5 stocks bought by FIIs, MFs and retail investors rally up to 60% in 6 monthsAround 22 stocks with a market capitalisation above Rs 3,000 crore saw a rare alignment, with FIIs, mutual funds and retail investors all i...
- Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
- Liotech Industries shares list at 20% discount from IPO price on BSE SME platformThe Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- Tech-Led global selloff, Fed rate fears weigh on Indian equitiesIndian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE S...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Jio IPO: Akash, Isha and Anant Ambani to lead IPO process, says Mukesh AmbaniReliance Industries Chairman Mukesh Ambani announced that the board has approved the draft prospectus for the much-awaited IPO of Jio Platf...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- NSE vs BSE: Should investors buy BSE shares now or wait for one of the biggest IPOs in India?NSE's DRHP filing brings its IPO closer, but analysts suggest BSE's stock has already priced in this event. While the listing offers a dire...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
Load More
